Can-Fite Biopharma Statistics
NYSE: CANFHealthcareBiotechnologyUSD
2.00-0.10 (-4.76%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Can-Fite Biopharma by the numbers
Can-Fite Biopharma has a market capitalization of $6.1 million based on 3.03M shares outstanding. With trailing EPS of $-13.23, Can-Fite Biopharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 27.4% below its 50-day average and 41.2% below its 200-day average.
Average daily trading volume is 388.00K shares, or about $775,996 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CANF valuation vs. peer median
| Metric | CANF | Peer median | Difference |
|---|---|---|---|
| Market cap | $6.06M | $6.15M | -1% |
| Avg. volume | 388.00K | 274.48K | +41% |
Peer median across 8 companies: IMNN, EVGN, KALA, ALZN, CELZ, XCUR, PULM, ADXN.
Valuation
- Market cap
- $6.06M
- EPS (TTM)
- $-13.23
- Shares outstanding
- 3.03M
Price and trading
- Previous close
- 2.10
- Open
- 2.10
- Day range
- 1.96 – 2.10
- 52-week range
- 1.96 – 12.40
- 52-week change
- -83.05%
- Beta
- —
- Volume
- 68.19K
- Average volume
- 388.00K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 28, 2025
Additional statistics
- Market Cap
- 6.06M
- Forward Pe
- -2.20
- Eps
- -13.23
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 12.40
- Week52 Low
- 1.96
- Avg Volume
- 388.00K
- Shares Outstanding
- 3.03M
- Ma50
- 2.75
- Ma200
- 3.40
- Earnings Date
- Aug 28, 2025
- Pct From52w High
- -83.87%
- Pct From52w Low
- 2.04%